The pre-hairpin intermediate of gp41 from the human immunodeficiency virus (HIV) is the target for two classes of fusion inhibitors that bind to the C-terminal region or the trimeric coiled-coil of N-terminal helices, thereby preventing formation of the fusogenic trimer of hairpins. Using rational design, two 36-residue peptides, N36
Virus-cell and cell-cell fusion mediated by the viral envelope glycoproteins (Env) 1 (1) gp41 and gp120 constitute the first step of infection and dissemination, respectively, of the human immunodeficiency virus (HIV) and hence represent a promising target for the development of antiviral therapeutics (2) . Following binding of gp120 to CD4 and a chemokine receptor, a conformational change occurs in the gp120/gp41 oligomer that leads to insertion of the fusion peptide of gp41 into the target membrane and ultimately membrane fusion (2, 3) . The structure of the ectodomain of both HIV and simian immunodeficiency virus gp41 in its fusogenic/postfusogenic state has been solved by NMR (4) and crystallography (5) (6) (7) (8) and shown to consist of a trimer of hairpins. Each subunit comprises long N-and C-terminal helices connected by a 25-30-residue loop. The N-helices form a parallel, trimeric coiled-coil in the interior of the complex surrounded by the C-terminal helices oriented antiparallel to the N-terminal helices (Fig. 1a, bottom) . Peptides derived from the C-and Nhelices inhibit Env-mediated fusion at nanomolar and micromolar concentrations, respectively (9 -12) . These peptides do not bind the fusion-active or postfusogenic state of gp41 as represented by the ectodomain of gp41 free in solution and are thought to interact with a pre-hairpin intermediate (2, 13, 14) in which the N-and C-helices are not associated and the trimeric coiledcoil of N-helices is exposed (Fig. 1a , top left). Peptides derived from the C-terminal helix, such as C34 (residues 628 -661 of HIV-1 Env) and T20 (residues 638 -673 of HIV-1 Env; currently in phase III clinical trials (15, 16) ) target the exposed face of the trimeric coiled-coil of N-helices (11, 13, 14, 17, 18) . Engineered constructs such as the chimeric protein N CCG -gp41 (19) , which features an exposed, stable, disulfide-linked, trimeric coiled-coil of N-helices grafted onto the minimal, thermostable ectodomain of gp41; peptides in which the trimeric coiled-coil of N-helices is stabilized by fusion to the GCN4 trimeric coiled-coil (12) ; and the protein 5-helix (20) , in which the internal trimeric coiled-coil of N-helices is surrounded by only two C-helices, specifically target the C-region in the pre-hairpin intermediate state (Fig. 1a , top left). In both instances, packing of the C-region onto the trimeric coiled-coil of N-helices is blocked, and hairpin formation is inhibited. Although the ectodomain of gp41 in free solution is highly thermostable (with a T m in excess of 100°C) (21) , it has been shown to exist as a monomer-trimer equilibrium (21, 22) . In the context of the fusion process, the trimeric coiled-coil of N-helices in the pre-hairpin intermediate state may also exist as a monomer-trimer equilibrium (4, 22, 23) . If this is indeed the case, blocking the formation of the fusion-competent, homotrimeric coiled-coil of N-helices may provide another molecular target for inhibiting HIV cell fusion. In this article, we present the design and characterization of a peptide, derived from the N-helix of gp41, in which the sites of interaction with the C-helices have been mutated, but the sites of intermolecular contacts between the N-helices have been preserved. This peptide, which we term N36
Mut(e,g)
, is about 50-fold more effective in inhibiting HIV Env-mediated cell fusion than the N36 peptide (residues 546 -581 of HIV-1 Env) of gp41 from which it was derived. These data strongly suggest that the homotrimeric coiled-coil of N-helices in the pre-hairpin state can be disrupted.
EXPERIMENTAL PROCEDURES
Peptides-All peptides (Fig. 2b) , purchased from Commonwealth Biotechnologies (Richmond, VA), were synthesized on a solid phase support, purified by reverse phase high pressure liquid chromatography, and verified for purity by mass spectrometry and amino acid composition. All peptides bear an acetyl group at the N terminus and an amide group at the C terminus. Concentrations of peptides were determined spectrophotometrically: the calculated A 280 values (1-cm path length) for a concentration of 1 mg/ml N36, N36
Mut(e,g) , N36 (2) . In the pre-hairpin intermediate state, the N-region (red) is thought to consist of a trimeric, parallel helical coiled-coil; the fusion peptide (green) located at the N terminus of the ectodomain of gp41 is inserted into the target cell membrane; the C-region (blue) of gp41 is anchored to the viral membrane by a transmembrane segment (purple). Peptides derived from the C-region, such as C34 (11), bind to the N-region in its trimeric coiled-coil state; the proteins N CCG -gp41 (19) and 5-helix (20) , which expose either the complete or a portion of the N-region trimeric coil-coil in a stable form, bind to the C-region.
N36
Mut(e,g) , the subject of the present article, has been designed to remove the interaction surface between the N-and C-regions and therefore can only interact with the N-region in a monomeric form, thereby disrupting the homotrimeric coiled-coil N-region and resulting in the formation of heterotrimers. In all three instances, the fusion inhibitors block the formation of the trimer of hairpins, thereby preventing apposition of the viral and target cell membranes. b, as a consequence of the existence of a monomertrimer equilibrium for the trimeric coiledcoil of N-helices, the interaction of homotrimeric N36
Mut(e,g) (yellow) with the fusion-competent homotrimeric pre-hairpin intermediate (N-helices in red) results in subunit exchange and the formation of fusion-incompetent heterotrimers. responding to 0.7-0.8 A 280 ) were recorded at 25°C on a JASCO J-720 spectropolarimeter using a 0.05-cm path length cell. Quantitative evaluation of secondary structure from the CD spectrum was carried out using the program CDNN (www.bioinformatik.biochemtech.uni-halle. de/cd_spect/index.html; Ref. 24) .
Sedimentation Equilibrium-Sedimentation equilibrium experiments were conducted at 20.0°C and three different rotor speeds (16,000, 20,000, and 24,000) on a Beckman Optima XL-A analytical ultracentrifuge. Peptide samples were prepared in 50 mM sodium formate buffer (pH ϭ 3) and loaded into the ultracentrifuge cells at nominal loading concentrations of ϳ0.2 and 0.7-0.8 A 280 . Data were analyzed in terms of a single ideal solute to obtain the buoyant molecular mass, M(1 Ϫ v), using the Optima XL-A data analysis software (Beckman). The value for the experimental molecular mass M was determined using calculated values for the density (determined at 20°C using standard tables) and partial specific volume v (calculated on the basis of amino acid composition (25) ).
Cell Fusion Assay-Inhibition of HIV Env-mediated cell fusion by peptides was carried out as described previously (19) using a modification (26) of the vaccinia virus-based reporter gene assay (using soluble CD4 at a final concentration of 200 nM). B-SC-1 cells were used for both target and effector cell populations. Target cells were co-infected with vCB21R-LacZ and vCBYF1-fusin (CXCR4), and effector cells were coinfected with vCB41 (Env) and vP11T7gene1 at a multiplicity of infection of 10. For inhibition studies, peptides were added to an appropriate volume of Dulbecco's modified Eagle's medium (2.5%) and phosphatebuffered saline to yield identical buffer compositions (100 l) followed by addition of 1 ϫ 10 5 effector cells (in 50 l of medium) per well. After incubation for 15 min, 1 ϫ 10 5 target cells (in 50 l) and soluble CD4 were added to each well. Following 2.5 h of incubation, ␤-galactosidase activity of cell lysates was measured (A 570 ; Molecular Devices 96-well spectrophotometer) upon addition of chlorophenol red-␤-D-galactopyranoside (Roche Molecular Biochemicals). The curves for %fusion versus peptide inhibitor concentration were fit by nonlinear least-squares optimization using the program FACSIMILE (27, 28) . Fig. 2a illustrates the interactions between the N-helices and between the N-and C-helices as observed in both the NMR (4) and x-ray (5-8) structures of the fusogenic/postfusogenic state of the ectodomain of gp41. Internal contacts between the Nhelices involve positions a and d of the helical wheel (5). Each C-helix interacts with two N-helices (one intra-and the other intersubunit): these contacts involve positions e and g of the N-helices and positions a and d of the C-helix (5). The first crystal structure of the HIV-1 gp41 ectodomain core consisted of a complex of N36 and C34 peptides comprising residues 546 -581 and 628 -661, respectively, of HIV-1 Env (5). Using the N36 and C34 peptides as starting points, we designed two peptides: N36
RESULTS AND DISCUSSION

Design of Peptide Inhibitors-The helical wheel diagram in
Mut(e,g) , which can only undergo self-association but cannot interact with C34, and N36
Mut(a,d) , which can no longer self-associate but could potentially still interact with C34 ( Fig. 2b ). In the case of N36
Mut(e,g) , the residues at positions e and g of N36 have been replaced by residues at positions e and g of C34. Since the latter residues are located on the external surface of C34 in the context of the ectodomain gp41 core (4 -8) and since C34 on its own is monomeric (29) , 2 this set 1 gp41, and the C34 peptide comprises residues 628 -661 of the C-region of HIV-1 gp41. N36 and C34 associate to form a six-helix bundle whose structure has been solved crystallographically (5). In the N36
Mut(e,g) mutant, the residues at positions e and g of N36 have been substituted by residues at positions e and g, respectively, of C34; this effectively removes the interaction surface with C34 but preserves the contacts necessary to form a trimeric coiled-coil of N-helices. In the N36
Mut(a,d) mutant, the residues at positions a and d of N36 have been substituted by residues at positions f and c, respectively, of C34; this removes the contacts necessary to form the trimeric coilcoil of N-helices but preserves the interaction sites with C34.
of substitutions will prevent any interaction between N36
Mut(e,g) and the C-region of gp41 in its pre-hairpin intermediate state while preserving the intermolecular contacts required to form the trimeric coiled-coil of N-helices. In the case of N36
Mut(a,d) , the residues at positions a and d of N36 have been substituted by residues at positions f and c of C34, which Mut(e,g) , which corresponds to a trimer. An independent run for N36
Mut(e,g) at a concentration of 36 M in monomer (A 280 ϳ 0.2) yielded a molecular mass of 12,500 Ϯ 180 Da. b, CD spectrum of N36
Mut(e,g) and N36
Mut(a,d) . The calculated helical content is ϳ80% for N36
Mut(e,g) and ϳ20% for N36 Mut(a,d) . deg, degrees.
are located on the solvent-exposed face of the ectodomain core of gp41 (4 -8) , thereby removing the intermolecular contacts required to form the trimeric coiled-coil of N-helices. Mut(e,g) and N36
Mut(a,d) are presented in Fig. 3a . N36 Mut(e,g) behaves as a single monodisperse species at concentrations of ϳ36 M (in monomer; A 280 ϳ 0.2) and ϳ124 M (in monomer; A 280 ϳ 0.7) with a molecular mass of ϳ12,000 -12,500 Da, corresponding to a trimer. In this context it is worth noting that N36 on its own aggregates and does not form a well defined trimer (12), 2 presumably due to further self-association involving the predominantly hydrophobic residues at positions e and g, which have been substituted by predominantly hydrophilic residues in N36
Mut(e,g) (Fig. 2b) . N36 Mut(a,d) also behaves as a single monodisperse species at a concentration of ϳ140 M (A 280 ϳ 0.8), but its molecular mass is only ϳ3700 Da, corresponding to a monomer.
CD spectra of N36 Mut(e,g) and N36 Mut(a,d) are shown in Fig.  3b . N36
Mut(e,g) displays a double minimum at 208 and 222 nm, characteristic of an ␣-helix; and quantification of the CD data (24) indicates a helical content of ϳ80%. N36 Mut(a,d) , on the other hand, is largely random coil (characterized by a minimum around 200 nm) with a small amount of ␣-helix (ϳ20%).
We were unable to detect any evidence of interaction between either N36
Mut(e,g) or N36 Mut(a,d) and C34 by either analytical ultracentrifugation or CD. The absence of interaction between N36
Mut(e,g) and C34 is exactly as predicted from the design since the points of contact with C34 have been mutated (cf. Fig. 2 ). The absence of interaction between N36
Mut(a,d) and C34 was initially somewhat surprising since the residues that contact C34 in the context of the fusogenic/postfusogenic state of the gp41 ectodomain were preserved. This result therefore indicates that C34 can only form a complex with a stable trimeric coiled-coil of N-helices. From a structural standpoint, this is readily understood since each C-helix contacts two Nhelices of the trimeric coiled-coil (one intramolecular and the other intersubunit; cf. Fig. 2a) , and the buried surface area for each of the two interactions is comparable.
To exclude the remote possibility that N36 Mut(e,g) could behave in a manner analogous to C34 and bind to the surface of the trimeric coiled-coil of N-helices in the pre-hairpin intermediate of gp41, we also examined the interaction of N36
Mut(e,g) with the engineered protein N CCG -gp41. N CCG -gp41 is a chimeric protein that features an exposed trimeric coiled-coil of N-helices that is stabilized both by fusion to a minimal thermostable ectodomain of gp41 and by engineered intersubunit disulfide bonds (19) . The exposed trimeric coiled-coil of Nhelices in N CCG -gp41 mimics that of the pre-hairpin intermediate of gp41, but in contrast to native gp41, the N-helices cannot dissociate since they are covalently tethered by disulfide bonds. Analytical ultracentrifugation on various mixtures of N36
Mut(e,g) and N CCG -gp41 in ratios of 4.5:1 and 11.7:1 (24 M N36
Mut(e,g) plus 5.3 M N CCG -gp41 and 51 M N36 Mut(e,g) plus 4.4 M N CCG -gp41, respectively, with concentrations expressed in trimer) provided no evidence of any interactions between these two molecules, and the data were readily accounted for by a mixture of two ideal species.
Inhibition of HIV Env-mediated Cell Fusion-
The results of a quantitative vaccinia virus-based reporter gene assay (26) for HIV Env-mediated cell fusion are shown in Fig. 4 . N36 inhibits fusion with an IC 50 of 16 Ϯ 2 M in agreement with previous results (19) . N36
Mut(e,g) inhibits fusion with an IC 50 308 Ϯ 22 nM. Thus N36
Mut(e,g) is ϳ50-fold more active in inhibiting fusion than N36. N36
Mut(a,d) , on the other hand, fails to inhibit fusion even at concentrations as high as 0.1 mM. The lack of any fusion-inhibitory activity for N36 Mut(a,d) is exactly as predicted from the biophysical data since N36 Mut(a,d) does not self-associate and does not interact with C34.
Since N36 Mut(e,g) forms a well defined trimeric species that does not interact with either C34 or the chimeric protein N CCGgp41 (in which the N-helices of the solvent-exposed trimeric coil-coil are covalently linked by interhelical disulfide bonds), it must target the N-region of the pre-hairpin intermediate by forming fusion-incompetent heterotrimers (Fig. 1b) . Analytical ultracentrifugation on the ectodomain of gp41 indicates the presence of only monomer and trimer species in equilibrium (21, 22) ; that is, assembly of the trimer is a highly cooperative process. The fusion-inhibitory activity of N36
Mut(e,g) therefore indicates the presence of a dynamic equilibrium between monomeric and trimeric forms of membrane-bound gp41 that allows subunit exchange to take place in the pre-hairpin intermediate state. The rate of exchange between these species must be sufficiently fast to permit efficient heterotrimer formation within the lifetime (ϳ15 min) of the pre-hairpin intermediate (13, 30, 31) .
Modeling Inhibition of HIV Env-mediated Cell Fusion by N36
Mut(e,g) -The inhibition curve for N36 Mut(e,g) is well fit by a simple Langmuir isotherm given by %fusion ϭ 100/(1 ϩ [N36 Mut(e,g) ]/IC 50 ) (Fig. 4) . Yet, mechanistically, the interaction 
of N36
Mut(e,g) with the pre-hairpin intermediate of gp41 is far more complex, involving multiple species in different homoand hetero-oligomerization states. The simplest scheme describing the situation is presented in Fig. 5a . L and M represent N36
Mut(e,g) and the pre-hairpin intermediate of gp41 in their monomeric forms, respectively; LL and MM are homodimers; ML is a heterodimer; LLL and MMM are homotrimers; and MML and MLL are heterodimers. We assume that only the homotrimer MMM is fusion-active, and the fraction fusion activity is given by the ratio of The interactions between ligand (in its various oligomerization states) and membrane-bound protein (in its various homo-and hetero-oligomeric states) are described by their respective bulk solution concentrations. The interactions involving only membrane-bound species, however, are dependent on their concentrations in the two-dimensional membrane (i.e. number of molecules per unit area) that are much higher than their concentrations in bulk solvent. In terms of thermodynamics, all equilibria in Fig. 5a can be related to the species concentrations in bulk solvent by multiplying the relevant equilibrium constants by a factor to yield appropriate apparent equilibrium constants (Fig. 5a, middle panel) .
The measured equilibrium association constant K ref trimer for the ectodomain of HIV-1 gp41 in free solution (i.e. the trimer of hairpins) is 4.8 ϫ 10 11 M Ϫ2 and is given by the product of the equilibrium association constants K 1 (monomer-dimer equilibrium) and K 2 (dimer-trimer equilibrium) (Fig. 5a, bottom panel) . Since trimerization of the gp41 ectodomain is highly cooperative (21, 22) , K 2 Ͼ Ͼ K 1 . Taking Fig. 5a as a function of total ligand concentration, L T , were calculated numerically by integration of the differential equations describing the reactions to essentially infinite time.) The optimized values of ␣ and ␤ depend on the product M T , and the results are therefore equally valid for a wide range of M T concentrations. The data can be equally well fitted for values of M T ranging from 10 Ϫ7 to 10 Ϫ3 M with ␣ varying from ϳ10 to 0.1 and ␤ varying from 1 to 10 (Fig. 5b) . Best fits to the experimental fusion inhibition data for M T ϭ 1.5 ϫ 10 Ϫ5 and 1.5 ϫ 10 Ϫ4 M are shown in Fig. 5c ; the optimized values of ␣ are 1.07 and 0.34 (with error estimates of ϳ40%), respectively, and of ␤ are 2.97 and 5.76 (with error estimates of 10%), respectively. The resulting curves are essentially indistinguishable from each other as well as from that obtained with a Langmuir isotherm. The occupancy of the various species relative to M T and L T are shown in Fig. 5, d and e, respectively. For this set of parameters, the fraction M in the trimeric state in the absence of ligand is ϳ86% for M T ϭ 1.5 ϫ 10 Ϫ5 M and ϳ97% for M T ϭ 1.5 ϫ 10 Ϫ4 M; the value of L T at which 50% of L is monomeric is ϳ2 ϫ 10 Ϫ6 and 5 ϫ 10 Ϫ6 M, respectively. The occupancy of homodimeric ligand is less than 1% of L T ; likewise the occupancy of homodimeric (MM) and heterodimeric (LM) protein is less than 1% of M T for all values of L T . Both MML and MLL heterotrimers are formed with the MML heterotrimer peaking at concentrations of L T slightly less than that at which 50% of the ligand is monomeric.
The above calculations reveal two important findings. First, despite the complexities introduced by multiple homo-and hetero-oligomerization states, which might lead one to predict a complex relationship between fusion and total ligand concentration, a scheme such as that depicted in Fig. 5a can still yield rather simple inhibition data that is readily characterized by a Langmuir isotherm. Second, the values for the various equilibrium constants for trimerization required to best fit the experimental fusion data are entirely compatible with the experimentally measured value for the equilibrium constant for trimerization of the ectodomain of HIV-1 gp41 in solution.
In the best fit calculations described above and depicted in Fig. 5 , only the homotrimeric form of the pre-hairpin intermediate of gp41, MMM, is considered to be fusion-active. If the calculations are repeated assuming that the heterotrimer, MML, containing only one molecule of N36
Mut(e,g) , is also fusion-active, the resulting theoretical curves do not reproduce the experimental data. One can therefore conclude that the energetics of formation of a five-helix bundle comprising a heterotrimeric internal coiled-coil consisting of two N-helices of gp41 and one N36
Mut(e,g) helix surrounded by two C-helices of gp41 is not sufficiently favorable to bring the target and viral membranes into sufficiently close proximity for fusion to take place.
Concluding Remarks-Using rational design, we have engineered two peptides derived from the N-helix of the ectodomain of gp41. The parent peptide, N36, corresponds to residues 546 -581 of HIV-1 Env and encompasses the N-terminal helix of gp41. The N36 Mut(a,d) peptide was designed to remove interactions leading to self-association and the formation of a trimeric coiled-coil of N-helices while preserving those residues that interact with the C-helix of the ectodomain of gp41. The absence of any fusion-inhibitory activity of N36 Mut(a,d) leads us to conclude that the C-region of gp41 can only interact with a trimeric coiled-coil of N-helices. The N36
Mut(e,g) peptide was designed to preserve the interactions leading to self-association while replacing those residues that interact with the C-region.
N36
Mut(e,g) forms a monodisperse trimer in solution that does not interact with the C-region of gp41 and yet still inhibits fusion about 50-fold more effectively than the native gp41 sequence (i.e. N36) from which it was derived. These results can only be explained by the existence of a dynamic equilibrium between monomeric and trimeric coiled-coil forms of the Nregion of gp41 in the pre-hairpin intermediate on a time scale sufficiently fast to permit subunit exchange and the consequent formation of heterotrimers of the N-helices of gp41 and N36
Mut(e,g) . Thus, N36 Mut(e,g) disrupts the homotrimeric coiledcoil of N-helices in the pre-hairpin intermediate state of gp41 and represents a novel third class of gp41-targeted fusion inhibitor. The other two classes of inhibitors bind to either the homotrimeric coiled-coil of N-helices (e.g. C34 and T20) or to the exposed C-region (e.g. N CCG -gp41 and 5-helix) of gp41 in the pre-hairpin intermediate state. Since C34 (and presumably T20) also binds to N CCG -gp41 and 5-helix (19, 20) , these two classes of inhibitors antagonize each other. In contrast, one would predict that the N36
Mut(e,g) class of inhibitors should act either additively or synergistically with either of the other two classes. Therefore, N36
Mut(e,g) may represent a promising lead for the design of clinically effective, novel fusion inhibitors.
